World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
26932
World Ranking
16532
National Ranking
8306

Overview

Timothy M. Kuzel is affiliated with Rush University Medical Center in the United States. Their research spans multiple fields within the biomedical sciences, with a focus on medicine and biochemistry, genetics, and molecular biology.

The scientist's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of research encompass oncology, molecular biology, pulmonary and respiratory medicine, immunology, and cancer research. This reflects a broad engagement with both clinical and molecular aspects of human disease.

Key research topics covered in Kuzel's work are:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Renal Cell Carcinoma Treatment
  • Prostate Cancer Treatment and Research
  • CAR-T Cell Therapy Research
  • Immunotherapy and Immune Responses
  • Wound Healing and Treatments

Kuzel has contributed to numerous scientific publications, including papers that address infectious diseases, cancer classification, and clinical practice guidelines. Some of the recent papers are:

  • Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics (2023), published in Cells
  • Refining Colorectal Cancer Classification and Clinical Stratification Through a Single-Cell Atlas (2022), published in Genome Biology
  • Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease (2022), published in JAMA Oncology
  • A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma (2021), published in European Urology
  • Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer (2020), published in International Journal of Molecular Sciences

Frequently publishing in high-impact journals, Kuzel's work has appeared predominantly in:

  • Journal of Clinical Oncology
  • Blood
  • International Journal of Molecular Sciences
  • Journal for ImmunoTherapy of Cancer
  • Genome Biology

Kuzel has collaborated extensively with other researchers. The most frequent co-authors include:

  • Jochen Reiser
  • Sasha H. Shafikhani
  • Ashiq Masood
  • Ruchi Roy
  • Sam G. Pappas

Best Publications

  • Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

    Elise A. Olsen;Youn H. Kim;Timothy M. Kuzel;Theresa R. Pacheco

  • Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

    Robert J. Motzer;Brian I. Rini;David F. McDermott;Bruce G. Redman

  • gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

    Douglas J. Schwartzentruber;David H. Lawson;Jon M. Richards;Robert M. Conry

  • Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

    Charles L. Bennett;Samuel M. Silver;Benjamin Djulbegovic;Athena T. Samaras

  • Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

    Elise Olsen;Madeleine Duvic;Arthur Frankel;Youn Kim

  • Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

    Naomi B. Haas;Judith Manola;Robert G. Uzzo;Keith T. Flaherty

  • NCCN clinical practice guidelines in oncology: kidney cancer.

    Robert J Motzer;Neeraj Agarwal;Clair Beard;Graeme B Bolger

  • NCCN Task Force Report: Oral chemotherapy.

    Saul N. Weingart;Elizabeth Brown;Peter B. Bach;Kirby Eng

  • Pure red-cell aplasia and epoetin therapy

    Charles L. Bennett;Stefano Luminari;Allen R. Nissenson;Martin S. Tallman

  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    H Miles Prince;H Miles Prince;Youn H Kim;Steven M Horwitz;Reinhard Dummer

  • Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.

    C L Bennett;M R Ferreira;T C Davis;J Kaplan

  • Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology

    James L. Mohler;Philip W. Kantoff;Andrew J. Armstrong;Robert R. Bahnson

  • Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

    W M Stadler;T Kuzel;B Roth;D Raghavan

  • Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    Julia J. Scarisbrick;H. Miles Prince;Maarten H. Vermeer;Pietro Quaglino

  • Bladder cancer. Clinical practice guidelines in oncology.

    Peter E. Clark;Neeraj Agarwal;Matthew C. Biagioli;Mario A. Eisenberger

  • Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer

    Donald Kaufman;Derek Raghavan;Michael Carducci;Ellis Glenn Levine

  • Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts

    Tomi L. Pandolfino;Richard S. Siegel;Timothy M. Kuzel;Steven T. Rosen

  • Small cell carcinoma of the urinary bladder

    Liang Cheng;Chong-Xian Pan M.D.;Ximing J. Yang M.D.;Antonio Lopez-Beltran

  • Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up

    James J Herrmann;Henry H Roenigk;Arti Hurria;Timothy M Kuzel

  • Primary C utaneous B -Cell L ymphoma: R eview a nd C urrent Concepts

    Richard S. Siegel;Tomi Pandolfino;Joan Guitart;Steven Rosen

Frequent Co-Authors

Steven T. Rosen
Steven T. Rosen City Of Hope National Medical Center
Charles L. Bennett
Charles L. Bennett University of South Carolina
Madeleine Duvic
Madeleine Duvic The University of Texas MD Anderson Cancer Center
Alfred W. Rademaker
Alfred W. Rademaker Northwestern University
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Youn H. Kim
Youn H. Kim Stanford University
Kim Margolin
Kim Margolin City Of Hope National Medical Center
Ximing J. Yang
Ximing J. Yang Northwestern University
Elizabeth R. Plimack
Elizabeth R. Plimack Fox Chase Cancer Center
Michael A. Carducci
Michael A. Carducci Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine but want flexible options, there are several online degrees and pathways worth considering. Many healthcare roles require advanced credentials, and online programs now make it easier to balance education with your work or personal commitments.

For registered nurses aiming to specialize, adn to fnp bridge programs allow you to transition quickly from an ADN to a Family Nurse Practitioner role. Those seeking to advance from RN status can explore rn to bsn online no clinicals accredited programs, which are ideal for working nurses who need flexibility.

Interested in health leadership? top cahme-accredited mha programs can help you qualify for management positions in hospitals and healthcare organizations. If your interest lies in food and wellness, an online bachelor's in nutrition can lead to opportunities in dietetics, public health, and related fields.

These diverse online pathways increase accessibility to healthcare careers, making it easier for students with different backgrounds and goals to find the right fit.

Best Scientists Citing Timothy M. Kuzel

Trending Scientists